577 related articles for article (PubMed ID: 25795054)
1. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
4. Comment on 'Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model' by Choi J.H. et al. [Exp. Eye Res. 134 (2015) 53-62].
Erdemli HK; Akyol S; Armutcu F; Akyol O
Exp Eye Res; 2015 Sep; 138():124-5. PubMed ID: 26166164
[No Abstract] [Full Text] [Related]
5. Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils.
Toyoda T; Tsukamoto T; Takasu S; Shi L; Hirano N; Ban H; Kumagai T; Tatematsu M
Int J Cancer; 2009 Oct; 125(8):1786-95. PubMed ID: 19610061
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
7. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
8. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
11. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
[TBL] [Abstract][Full Text] [Related]
12. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
[TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
15. Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice.
Hsu SM; Yang CH; Tsai HY; Lin CJ; Fang YH; Shieh CC; Chen SH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171990
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice.
Chen J; Vistica B; Wiggert B; Chan CC; Gery I
Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764
[TBL] [Abstract][Full Text] [Related]
17. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
18. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
19. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
20. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
Usui M
Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
